We are live on ! Find out more
LD

Lipe & Dalton Portfolio holdings

AUM $215M
1-Year Est. Return 39.53%
This Fund
S&P 500
This Quarter Est. Return
+16.18%
1 Year Est. Return
+39.53%
3 Year Est. Return
+89.64%
5 Year Est. Return
+111.74%
10 Year Est. Return
+427.59%
AUM
$163M
AUM Growth
+$18.8M
Cap. Flow
-$2.4M
Cap. Flow %
-1.48%
Top 10 Hldgs %
38.03%
Holding
103
New
7
Increased
25
Reduced
36
Closed
3

Top Buys

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$1M
2
C icon
Citigroup
C
+$266K
3
MLM icon
Martin Marietta Materials
MLM
+$176K
4
EXEL icon
Exelixis
EXEL
+$139K
5
BIIB icon
Biogen
BIIB
+$92.9K

Top Sells

Rank Stock Value
1
ALSN icon
Allison Transmission
ALSN
+$958K
2
MCK icon
McKesson
MCK
+$931K
3
BCE icon
BCE
BCE
+$646K
4
FTV icon
Fortive
FTV
+$311K
5
CARR icon
Carrier Global
CARR
+$206K

Sector Composition

Rank Sector Weight
1 Technology 21.47%
2 Healthcare 21.14%
3 Financials 17.22%
4 Industrials 14.62%
5 Communication Services 7.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MO icon
101
Altria Group
MO
$122B
– –
-675
Closed -$26K
ODFL icon
102
Old Dominion Freight Line
ODFL
$48.5B
– –
-240
Closed -$22K
1 2 3 4
5

Similar funds

VEA
Virtus ETF Advisers New York $215M AUM 53.68% 1-Year Est. Return
NCM
NEXTBio Capital Management Menlo Park, California $215M AUM
VFG
V2 Financial group Naperville, Illinois $215M AUM 15.18% 1-Year Est. Return
SSA
SSA Swiss Advisors Zurich $216M AUM 17.86% 1-Year Est. Return
LIWM
Long Island Wealth Management Melville, New York $216M AUM 14.59% 1-Year Est. Return
IAM
Impala Asset Management Palm Beach, Florida $215M AUM 86.77% 1-Year Est. Return
1M
1248 Management Kansas City, Missouri $216M AUM 12.29% 1-Year Est. Return
GC
GatePass Capital Independence, Ohio $214M AUM 29.83% 1-Year Est. Return

Lipe & Dalton's Q4 2020 Portfolio in Review

As of Q4 2020, Lipe & Dalton held 103 positions worth $163M, up 13% from $144M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Lipe & Dalton's Q4 2020 filing shows 7 new, 25 increased, 36 reduced and 3 closed positions. Its largest new stake was Vertex Pharmaceuticals: 4,380 shares worth $1.03M. The largest sale was Allison Transmission, an estimated $958K.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Healthcare and Financials.

  • Lipe & Dalton's largest Q4 2020 buy was Vertex Pharmaceuticals: 4,380 shares worth $1.03M.
  • Lipe & Dalton added most to Citigroup in Q4 2020, an estimated $266K increase.
  • Lipe & Dalton's biggest Q4 2020 reduction was Allison Transmission, cutting an estimated $958K.
  • Lipe & Dalton fully exited IBM in Q4 2020, selling an estimated $140K.
  • Lipe & Dalton's ten largest holdings make up 38% of its $163M portfolio in Q4 2020.
  • Lipe & Dalton opened 7 new positions and closed 3 in Q4 2020.
  • Lipe & Dalton's portfolio value rose 13% quarter-over-quarter to $163M.

Based on Lipe & Dalton's 13F filing for Q4 2020, filed 29 Jan 2021.